Tag - covid-19

 
 

COVID 19

Japan Times
WORLD / Science & Health
Sep 24, 2021
U.S. CDC advisers back COVID-19 booster shots for older people but not for high-risk workers
Beyond older Americans, the committee also recommended the shots for all adults over 50 with underlying conditions, as well as some 18- to 49-year-olds with those conditions.
Japan Times
JAPAN / Explainer
Sep 23, 2021
Japan prepares booster shots amid worries over waning vaccine efficacy
Preparations have begun to administer additional shots to health care workers and older people, but debate still swirls around how extra doses should be given and when.
Japan Times
WORLD
Sep 23, 2021
Under pressure, U.S. pledges 500 million more COVID-19 vaccine doses globally
Health experts say the planned donations are welcome but insufficient, and that the Pfizer vaccine is difficult to administer in poorer countries that lack sophisticated infrastructure.
Japan Times
WORLD
Sep 23, 2021
FDA approves Pfizer booster for older, at-risk people in U.S.
While less broad than some had hoped, the authorization leaves the door open for the FDA to consider broader use of boosters, including in younger adults.
Japan Times
JAPAN / FOCUS
Sep 21, 2021
COVID-19's classification in Japan is limiting treatment. Now doctors want it changed.
COVID-19's status in Japan as a new influenza infection puts a heavy burden on public health centers and restricts when and where patients can receive medical care.
Japan Times
WORLD
Sep 21, 2021
Biden’s vaccine booster and export plans collide at summit
The U.S. plan for boosters has angered nations where many people are still struggling to obtain a first shot.
Japan Times
BUSINESS / Economy / FOCUS
Sep 21, 2021
Haruhiko Kuroda's monetary experiment set to continue beyond BOJ tenure record
Reaching the landmark as longest-running governor will be testament to Kuroda's ability to keep political and market pressure at bay despite having failed to spark inflation.
Japan Times
JAPAN / Explainer
Sep 20, 2021
Questions answered about vaccine effectiveness against the delta variant
With the strain of the virus running rampant in parts of the world, and having an effect on Japan, researchers are keen to find ways to deal with it.
Japan Times
WORLD
Sep 20, 2021
Pfizer COVID-19 shot safely bolsters antibodies in younger kids
In a trial, two shots of a 10 microgram dose — one-third of the adult shot — produced antibody levels comparable to those seen in a trial of 16- to 25-year-olds who got the adult dose.
Japan Times
JAPAN
Sep 20, 2021
Experts reach out to Japanese youths to debunk COVID-19 vaccine myths
The government is making a renewed push to allay concerns over the vaccines' safety, but they face an uphill battle against the disinformation rife on social media.
Japan Times
WORLD
Sep 20, 2021
Pfizer shot’s protection against hospitalization wanes in study
After four months, Moderna's vaccine was 92% effective against hospitalization, with Pfizer's at 77% and Johnson & Johnson's at 68%.
Japan Times
WORLD / Politics
Sep 20, 2021
Vaccine debate and climate goals top a scaled-back U.N. summit
The U.N. wants diplomats to have the face-to-face time they need to address crisis issues, but they don't want to be remembered for hosting a superspreader event.
Japan Times
JAPAN / FOCUS
Sep 19, 2021
Home COVID-19 care surged as Japan's hospitals filled up, but treatment options were limited
Providing at-home treatment for coronavirus patients presents an entirely different dilemma for the nation's already exhausted medical personnel.
Japan Times
BUSINESS
Sep 19, 2021
COVID-19 was expected to spur a remote-work revolution in Japan. What happened?
A lack of digital infrastructure and an archaic corporate culture that values long working hours and face-to-face meetings is slowing down the nation's push toward working remotely.
Japan Times
JAPAN / Politics
Sep 18, 2021
COVID-19 in focus as LDP hopefuls make their case in wide-ranging debate
The government's response to the coronavirus crisis, the constitutionality of lockdowns and the challenge the pandemic has posed for the medical system were central themes on Saturday.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?